State Laws Regarding the Retention and Use of Residual Newborn Screening Blood Samples

摘要

BACKGROUND:After newborn screening has been completed, many states retain residual newborn screening dried blood samples for various purposes, including program evaluation, quality assurance, and biomedical research. The extent to which states possess legal authority to retain residual dried blood samples (DBS) and use them for purposes unrelated to newborn screening is unclear.